Dhaval T. has over 15 years of experience in the biopharmaceutical industry, focusing on regulatory affairs, quality management, and strategic planning. Dhaval has held various leadership roles in companies such as Syngene International Limited, Biopharma - Stelis, USV LIMITED, Biocon, INTAS Biopharmaceuticals Ltd., and Indus Biotherapeutics Ltd. Dhaval has demonstrated expertise in developing and executing product development strategies, engaging with regulatory agencies worldwide, and optimizing operational processes for cost savings and improved delivery performance.
April, 2019 - present